The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations. Boston Children’s Hospital invests heavily in research because science saves lives. We are focused on accelerating new treatments for devastating diseases — our discoveries translate from the laboratory bench to the patient’s bedside, where they have been improving the health of children and adults since 1869. Today, our research enterprise is the world's largest and most highly-funded at a pediatric hospital, investing $355 million in expenditures in fiscal year 2017 alone. In FY2018, Boston Children’s was #1 in National Institutes of Health funding for all U.S. children’s hospitals, and #6 in funding for research institutes at any independent hospital. More than 3,000 basic, clinical and translational research employees work in our dedicated facilities, which total nearly 1 million square feet of space.